JPS61165635A - Pretreatment of blood - Google Patents

Pretreatment of blood

Info

Publication number
JPS61165635A
JPS61165635A JP26711585A JP26711585A JPS61165635A JP S61165635 A JPS61165635 A JP S61165635A JP 26711585 A JP26711585 A JP 26711585A JP 26711585 A JP26711585 A JP 26711585A JP S61165635 A JPS61165635 A JP S61165635A
Authority
JP
Japan
Prior art keywords
oil
blood
blood specimen
xylene
specimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP26711585A
Other languages
Japanese (ja)
Other versions
JPS6310390B2 (en
Inventor
Hideyuki Horiuchi
堀内 秀之
Hisatake Yokouchi
久猛 横内
Ryuichi Suzuki
隆一 鈴木
Akihide Hashizume
明英 橋詰
Shinji Yamamoto
真司 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Original Assignee
Hitachi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Ltd filed Critical Hitachi Ltd
Priority to JP26711585A priority Critical patent/JPS61165635A/en
Publication of JPS61165635A publication Critical patent/JPS61165635A/en
Publication of JPS6310390B2 publication Critical patent/JPS6310390B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To enable the accurate calculation of a reticulocite by preventing the generation of a dummy reticulocite, by immersing a stained blood specimen in an org. solvent for a predetermined time and subsequently coating the blood specimen with oil for an oil immersion lens. CONSTITUTION:The blood specimens 102 received in a cassette 101 are immersed in xylene for 1-10min. Next, the blood specimens are extruded from the cassette 101 one at a time by a lever 106 in a stage raising said blood specimens from xylene while a proper amount of oil 104 is dripped on the surface of each blood specimen to uniformly coat the surface thereof with oil for an oil immersion lens. By this operation, xylene is penetrated in the deformed part of one which was a dummy reticulocite at first and the contamination of the blood specimen is removed by oil and the greater part of dummy reticulocites can be eliminated when the oil for the oil immersion lens was dripped and erroneous discrimination can be prevented.

Description

【発明の詳細な説明】 〔発明の利用分野〕 本発明は、超生体染色された血液標本の顕微鏡像により
赤血球とを識別し、網赤血球比率を算定する網赤血球算
定検査に用いる血液前処理方法に関する。
[Detailed Description of the Invention] [Field of Application of the Invention] The present invention provides a blood pretreatment method for use in a reticulocyte count test in which red blood cells are distinguished from red blood cells using a microscopic image of a supravital-stained blood specimen and the reticulocyte ratio is calculated. Regarding.

〔発明の背景〕[Background of the invention]

ニューメチレンブル−(New 5ethylene 
blue)等による超生体染色を施した新鮮血液標本に
おいて、帯緑黄色の赤血液中に紫青色の順位状物質およ
び紐状物質(網状体)がもつれあって存在する幼若な赤
血球が網赤血球である。核を有する赤芽球は骨髄内で脱
核して末梢血へと出てくるが、その過程で必らず網赤血
球の時期をへてくる。末梢血における網赤血球比率の増
減は、幼若赤血球の増減、すなわち赤血球生成能の昂進
減退をあられす、したがって、網赤血球の算定は、赤血
球生成を知る重要なパラメータである。このような網赤
血球比率の算定は超生体染色を施した新鮮血液標本を、
油浸対物レンズを用いた高倍率の光学顕微鏡で検鏡して
行なわれる。この場合、上記の血液標本の乾燥条件およ
び、検鏡までの経過した時間の長短により、個々の赤血
球中央付近に、しわ状の変形が発生することがある。こ
のように油浸法で検鏡する場合、赤血球の上記しわ状変
形が起こっている部分に油が浸透できず、赤血球の顕微
鏡像は網赤血球像と非常に似かよったものになってしま
う。このような赤血球を擬似網赤血球という。
New methylene blue
In fresh blood specimens that have been stained with supravital dyes such as blue, reticulocytes are immature red blood cells in which purplish-blue rank substances and string-like substances (reticular bodies) are entangled in greenish-yellow red blood. be. Nucleated erythroblasts enucleate within the bone marrow and emerge into the peripheral blood, but in the process they inevitably pass through the reticulocyte stage. An increase or decrease in the reticulocyte ratio in peripheral blood indicates an increase or decrease in immature red blood cells, that is, an increase or decrease in erythropoietic ability. Therefore, calculation of reticulocytes is an important parameter for understanding erythropoiesis. This calculation of the reticulocyte ratio is performed using fresh blood specimens that have been stained with supravital staining.
It is performed using a high-magnification optical microscope using an oil immersion objective. In this case, wrinkle-like deformation may occur near the center of each red blood cell, depending on the drying conditions of the blood sample and the length of time elapsed before microscopy. When examining the red blood cells using the oil immersion method, the oil cannot penetrate into the wrinkled areas of the red blood cells, resulting in a microscopic image of the red blood cells that is very similar to a reticulocyte image. Such red blood cells are called pseudoreticulocytes.

この擬似網赤血球の発生頻度は、少ない場合で赤血球1
000個に対し数個、多い場合に1000個以上に達す
るのに対し、IM赤血球の正常人の発生頻度は、赤血球
1000個に対し3〜11個と非常に少なく、擬似網赤
血球の存在は算定結果に大きな影響を与える。ことに1
例えば特公昭54−38758号公報等に提案さるよう
な自動化装置、すなわち血液標本の顕微鏡像の自動識別
処理により成熟した赤血球(以下単に赤血球と呼ぶ)と
網赤血球を識別し、網赤球率を算定する装置では、上記
の擬似網赤血球と真の網赤血球の識別は極めて困累であ
る。したがって血液標本中の擬似網赤血球の発生が網赤
血球算定を自動化する上で大きな障害となっていた6 〔発明の目的〕 そこで、本発明は真の網赤血球との識別が困難な擬似網
赤血球が血液標本中に生じるのを防止し。
The frequency of occurrence of this pseudoreticulocyte is, in rare cases, 1 red blood cell
In contrast, the frequency of IM red blood cells in normal people is very low at 3 to 11 per 1000 red blood cells, and the presence of pseudoreticulocytes is calculated. have a significant impact on the results. Particularly 1
For example, an automated device such as that proposed in Japanese Patent Publication No. 54-38758, etc., identifies mature red blood cells (hereinafter simply referred to as red blood cells) and reticulocytes by automatic identification processing of microscopic images of blood specimens, and calculates the reticulocyte percentage. It is extremely difficult to distinguish between the pseudo reticulocytes and true reticulocytes using a calculation device. Therefore, the occurrence of pseudo reticulocytes in blood specimens has been a major obstacle in automating reticulocyte calculation6. Prevent it from occurring in blood specimens.

もって正確な網赤血球算定を可能ならしめる血液前処理
方法を提供することを目的とする。
The object of the present invention is to provide a blood pretreatment method that enables accurate reticulocyte count.

〔発明の概要〕[Summary of the invention]

本発明の血液前処理方法は、超生体染色された血液標本
を有機溶剤中に所定時間浸たし、上記血液標本に顕微鏡
油浸レンズ用油を塗抹することを特徴とする。この方法
によれば、赤血球にしわ状変形が生じていたとしても検
鏡時に用いる油浸レンズ用油がしわ状変形部に十分に浸
透し、顕微鏡像には網状体とまぎられしい変形部分の像
が生じない。すなわち上記したような擬似赤血球は顕微
鏡像中に現れず、目視によっても、また画像自動処理に
よっても正確な網赤血球算定が可能となる。
The blood pretreatment method of the present invention is characterized by immersing a supravital-stained blood specimen in an organic solvent for a predetermined period of time, and smearing oil for a microscope oil immersion lens on the blood specimen. According to this method, even if wrinkle-like deformation occurs in red blood cells, the oil for the oil immersion lens used during microscopy sufficiently penetrates into the wrinkle-like deformation, and the microscopic image shows the deformed part that can be mistaken for a reticular body. No image is generated. That is, the above-mentioned pseudo red blood cells do not appear in the microscopic image, and accurate reticulocyte count can be performed both by visual inspection and by automatic image processing.

〔発明の実施例〕[Embodiments of the invention]

本発明の血液前処理方法を実施する血液標本前処理装置
の一例を第1図に示す。第10図において、lotは血
液標本102を収納するカセットケースであり、102
は超生体染色されている。
FIG. 1 shows an example of a blood specimen pretreatment apparatus for carrying out the blood pretreatment method of the present invention. In FIG. 10, lot is a cassette case that stores a blood specimen 102;
has been stained supravital.

103は有機溶剤(本実施例の場合キシレン)、104
は顕微鏡油浸レンズ用油、(例えば米国R,P、CAR
GILE  LABORATORrES。
103 is an organic solvent (xylene in this example), 104
is a microscope oil immersion lens oil (for example, US R, P, CAR
GILE LABORATORrES.

INC,社製のTYPEA)、105は上記油104を
血液標本102に導くチューブ、106は血液標本10
2を油の滴下位まで移動させるレバー、1.07は上記
レバー106の駆動部、108は、油滴下後に血液標本
102をカセット位置までおしもどす機構部である。カ
セット101に収納された血液標本102は、最初キシ
レン溶液103に1分ないし10分間浸たす。この浸た
す時間は、染色後の乾燥条件および経過時間によって調
節する。ただし、10分間以上浸たすと染色された赤血
球等が脱色し始めるため、長ずざるのは望ましくない。
TYPEA, manufactured by INC., Inc., 105 is a tube that guides the oil 104 to the blood specimen 102, and 106 is the blood specimen 10.
Reference numeral 2 is a lever that moves the blood sample 102 to the oil dripping position, reference numeral 1.07 is a driving portion of the lever 106, and reference numeral 108 is a mechanism portion that returns the blood specimen 102 to the cassette position after the oil is dripped. Blood specimen 102 stored in cassette 101 is first immersed in xylene solution 103 for 1 to 10 minutes. The soaking time is adjusted depending on the drying conditions and elapsed time after dyeing. However, if immersed for more than 10 minutes, stained red blood cells will begin to decolorize, so it is not desirable to soak for too long.

次に、血液標本をキシレン溶液から引上げる段階におい
て、レバー106で血液標本を1枚ごとに、カセット1
01から押し出し、この血液標本の表面に油104を。
Next, in the step of pulling up the blood specimen from the xylene solution, the lever 106 is used to pull the blood specimen one by one into the cassette.
01 and oil 104 on the surface of this blood specimen.

チューブ105から適当量滴下させて、血液標本の表面
に一様に油浸レンズ用油を塗抹する。なお、塗抹につい
てはスリット状の穴から油を押出す方法又は副手で油を
塗抹する方法でも良いことは勿論である。このとき、上
記のキシレン103が血液標本の表面から完全に蒸発し
てしまわない前に、できるだけ早く油を滴下することが
望ましい。滴下後、その血液標本をカセット101に再
セットする。次に、カセット101を血液標本1枚分だ
け上方向に移動させ、上記の操作を繰り返す。カセット
101の最下位の血液標本1.02は、キシレン溶液1
03に一番長く浸・していることになるから、この時間
が10分間を越えないようにすることが望ましい。
An appropriate amount of oil for an oil immersion lens is dripped from the tube 105 to evenly spread the oil for an oil immersion lens on the surface of the blood specimen. As for the smearing, it goes without saying that a method of pushing out the oil through a slit-like hole or a method of smearing the oil with a side hand may be used. At this time, it is desirable to drop the oil as soon as possible before the xylene 103 mentioned above completely evaporates from the surface of the blood sample. After dropping, the blood specimen is reset into the cassette 101. Next, the cassette 101 is moved upward by one blood specimen, and the above operation is repeated. The lowest blood sample 1.02 of the cassette 101 contains xylene solution 1.
Since this will be the longest period of immersion in 03, it is desirable that this time not exceed 10 minutes.

以上の操作を行なうと、最初擬似網赤血球であったもの
は、そのしわ状の変形部にキシレンが浸透するとともに
、油等による血液標本のよごれが′除去され、油浸レン
ズ用油を滴下した際、この油が上記しわ状の変形部に十
分浸透し、擬似網赤血球を大部分消失することができる
。もし、まだ擬似網赤血球が残っている血液標本に対し
ては上記の操作をもう1度くり返えし行なうことにより
完全に擬似網赤血球を取除くことができる。2度目の操
作では1度目で行った油浸レンズ用油が塗抹されたまま
の状態で、上記の操作をくり返してよい。
By carrying out the above operations, the xylene penetrated into the wrinkled deformed parts of what were originally pseudoreticulocytes, the stains from the blood sample due to oil etc. were removed, and the oil for oil immersion lenses was dropped. At this time, this oil can sufficiently penetrate into the wrinkle-like deformed areas and eliminate most of the pseudoreticulocytes. If pseudo reticulocytes remain in the blood specimen, repeating the above procedure once more will completely remove the pseudo reticulocytes. In the second operation, the above-mentioned operation may be repeated while the oil for the oil immersion lens that was performed in the first time is still smeared.

このようにして油浸レンズ用油が塗抹された血液標本は
、ただちに顕微鏡にて検鏡してもよいし、油自体は蒸発
しないため、以後長時間放置してもしわ状変形は解消さ
れた状態で保たれるので、時間をおいて検鏡してもよい
Blood specimens smeared with oil for oil immersion lenses in this way can be examined under a microscope immediately, and since the oil itself does not evaporate, the wrinkle-like deformation will disappear even if left for a long time. Since it is maintained in a stable condition, you can take a microscopic examination after some time.

以上の説明では、有機溶剤としてキシレンを用いた場合
について説明したが、■油浸レンズ用油を溶解すること
、■化学的に安定であり、金属、ガラス、生物資料及び
染色色素等と反応し。
In the above explanation, we have explained the case where xylene is used as an organic solvent; .

変性、溶解及び腐蝕等を起こさないこと、■揮発生があ
り、容易に除去し得ること等のキシレンと同様の効果を
有する有機溶剤を用いることができる。
An organic solvent can be used that has the same effects as xylene, such as not causing denaturation, dissolution, corrosion, etc., and (1) volatilization and being easily removable.

このような血液前処理方法によれば、擬似網赤血球の発
生頻度が赤血球1000個に対し100個以上であるよ
うな血液標本に対しても、擬似網赤血球の発生頻度を赤
血球1000個に対し1個以下と極めて減少させること
ができることが確認された。
According to such a blood pretreatment method, even for blood specimens in which the frequency of pseudoreticulocytes is 100 or more per 1000 red blood cells, the frequency of pseudoreticulocytes can be reduced to 1 per 1000 red blood cells. It was confirmed that it is possible to significantly reduce the amount to less than

〔発明の効果〕〔Effect of the invention〕

以上のように、本発明によれは血液標本中の擬似網赤血
球の発生率を極めて低くすることを可能とし、もって網
赤血球算定検査における赤血球と網赤血球の誤識別を防
止することができる。
As described above, according to the present invention, it is possible to extremely reduce the incidence of pseudoreticulocytes in a blood specimen, thereby preventing misidentification of red blood cells and reticulocytes in a reticulocyte counting test.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の処理方法を実施する処理装置の一例を
示す。 102・・・血液標本、103・・・有機8剤。 104・・・油浸レンズ用油 代理人 弁理士 小 川 勝 男29.−.。 ハ
FIG. 1 shows an example of a processing apparatus that implements the processing method of the present invention. 102...Blood specimen, 103...8 organic agents. 104... Oil agent for oil immersion lenses Patent attorney Katsuo Ogawa 29. −. . Ha

Claims (1)

【特許請求の範囲】 1、血液標本に超生体染色を施こし、油浸法による顕微
鏡像を得て赤血球と網赤血球とを識別する方法において
、染色された血液標本を所定時間有機溶剤に浸し、しか
る後該血液標本に油浸レンズ用油を塗抹することを特徴
とする血液前処理方法。 2、前記有機溶剤としてキシレンを用いることを特徴と
する特許請求の範囲第1項に記載の血液前処理方法。
[Scope of Claims] 1. A method in which a blood specimen is subjected to supravital staining and a microscopic image is obtained by an oil immersion method to identify red blood cells and reticulocytes, in which the stained blood specimen is immersed in an organic solvent for a predetermined period of time. , and then smearing oil for an oil immersion lens on the blood specimen. 2. The blood pretreatment method according to claim 1, characterized in that xylene is used as the organic solvent.
JP26711585A 1985-11-29 1985-11-29 Pretreatment of blood Granted JPS61165635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26711585A JPS61165635A (en) 1985-11-29 1985-11-29 Pretreatment of blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26711585A JPS61165635A (en) 1985-11-29 1985-11-29 Pretreatment of blood

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59065734A Division JPS6040954A (en) 1984-04-04 1984-04-04 Automatic calculator of reticulate erythrocytes

Publications (2)

Publication Number Publication Date
JPS61165635A true JPS61165635A (en) 1986-07-26
JPS6310390B2 JPS6310390B2 (en) 1988-03-07

Family

ID=17440271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26711585A Granted JPS61165635A (en) 1985-11-29 1985-11-29 Pretreatment of blood

Country Status (1)

Country Link
JP (1) JPS61165635A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009092617A (en) * 2007-10-12 2009-04-30 Sakura Finetek Japan Co Ltd Isolated living tissue placing apparatus and isolated living tissue fixing method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009092617A (en) * 2007-10-12 2009-04-30 Sakura Finetek Japan Co Ltd Isolated living tissue placing apparatus and isolated living tissue fixing method

Also Published As

Publication number Publication date
JPS6310390B2 (en) 1988-03-07

Similar Documents

Publication Publication Date Title
US10866171B2 (en) Accelerated Wright-Giemsa and May-Grünwald staining methods
US4911915A (en) Method of processing tissue specimens and dehydrant solvent for use therein
WO1992019952A1 (en) Improved staining method for histology and cytology specimens
US20040121485A1 (en) Removal of embedding media from biological samples and cell conditioning on automated staining instruments
US4209548A (en) Method for the preparation of blood samples for automated analysis
EP1422509A1 (en) Lysing Reagent and Method of Lysing Red Blood Cells for Hematology
JPS61165635A (en) Pretreatment of blood
KR102149623B1 (en) Method for quantitative determination of particle content using hydration state imaging
US6284543B1 (en) Rapid papanicolaou staining method for cervico-vaginal specimens
EP3739321B1 (en) Qualification method for cryoelectron microscopy samples and corresponding sample holder
EP1078240A1 (en) A method and a device for preparing a biological specimen
JP3226178B2 (en) Pup analysis method and apparatus
JP3212560B2 (en) Skin keratinocyte staining method
JP2002350431A (en) Decoloring method and device of stained specimen
CN114279795A (en) Rapid detection system, detection method and application of tissue sample
DE19802446A1 (en) Methods for analyzing semiconductor blanks
JPS6348020B2 (en)
Vriend et al. An improved direct intermicroscopic (LM→ SEM‐→ TEM) correlative procedure for the examination of mammalian skeletal muscle
LEVINE A METHOD FOR STAINING CONNECTIVE TISSUE MAST CEIJIJS”
Martin et al. Simple technique to facilitate tissue sampling for electron microscopy
CN113552105A (en) Method for detecting organic membrane pollution
EP4105706A1 (en) Method for correlative microscopy
SU1150520A1 (en) Method of determination of dispersion composition of oil/water-type fat liquors
WO2023147252A1 (en) Materials and methods for bleaching melanin-pigmented tissues
Bourne Analyzing Synaptic Ultrastructure with Serial Section Electron Microscopy